Moreover, the initial MR analysis revealed heterogeneity for the associations between Cystatin D and lung adenocarcinoma, Cystatin M (prot‐a‐703) and squamous cell lung carcinoma, and Cystatin F and NSCLC. Here, CST5 is linked to non-small cell lung carcinoma.